Jérôme Avouac

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 684 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Otylia Kowal‐Bielecka, Robert Landewé, Jérôme Avouac et al. · Annals of the Rheumatic Diseases · 2009 · 617 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

Jérôme Avouac, Jaap Fransen, U.A. Walker et al. · Annals of the Rheumatic Diseases · 2010 · 438 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

High N‐terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis

Yannick Allanore, Didier Borderie, Jérôme Avouac et al. · Arthritis & Rheumatism · 2007 · 242 citations

Medicine, Cardiology, Clinical Cardiology +12